Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

National High Blood Pressure Education Program.

Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2004 Aug.

2.

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute.; National High Blood Pressure Education Program Coordinating Committee..

Hypertension. 2003 Dec;42(6):1206-52.

3.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.; National High Blood Pressure Education Program Coordinating Committee..

JAMA. 2003 May 21;289(19):2560-72. Erratum in: JAMA. 2003 Jul 9;290(2):197.

PMID:
12748199
4.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program..

Can J Cardiol. 2009 May;25(5):287-98. Review.

5.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Cochrane Database Syst Rev. 2014 Feb 1;(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Review.

PMID:
24488616
6.

Cochrane in context: pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.

Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975. Review.

PMID:
25236306
7.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974. Review.

PMID:
25236305
8.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ; Canadian Hypertension Education Program..

Can J Cardiol. 2008 Jun;24(6):465-75. Review.

9.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program..

Can J Cardiol. 2007 May 15;23(7):539-50.

10.

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods.

Fukui T, Rahman M, Hayashi K, Takeda K, Higaki J, Sato T, Fukushima M, Sakamoto J, Morita S, Ogihara T, Fukiyama K, Fujishima M, Saruta T; CASE-J Study Group..

Hypertens Res. 2003 Dec;26(12):979-90. Review.

11.

2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.

Chiang CE, Wang TD, Ueng KC, Lin TH, Yeh HI, Chen CY, Wu YJ, Tsai WC, Chao TH, Chen CH, Chu PH, Chao CL, Liu PY, Sung SH, Cheng HM, Wang KL, Li YH, Chiang FT, Chen JH, Chen WJ, Yeh SJ, Lin SJ.

J Chin Med Assoc. 2015 Jan;78(1):1-47. doi: 10.1016/j.jcma.2014.11.005.

12.

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Campbell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Larochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Tobe S, Touyz RM; Canadian Hypertension Education Program..

Can J Cardiol. 2006 May 15;22(7):583-93.

13.

Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study.

de la Sierra A, Roca-Cusachs A, Redón J, Marín R, Luque M, de la Figuera M, Garcia-Garcia M, Falkon L; CENIT Study Working Group..

Clin Drug Investig. 2009;29(7):459-69. doi: 10.2165/00044011-200929070-00004.

PMID:
19499963
14.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program..

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142
15.

Treating hypertension with cardioprotective therapies: the role of ACE inhibitors, ARBs, and beta-blockers.

Staffileno BA.

J Cardiovasc Nurs. 2005 Sep-Oct;20(5):354-64. Review.

PMID:
16141781
16.
17.
18.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program..

Can J Cardiol. 2005 Jun;21(8):657-72.

PMID:
16003449
19.

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.

Musini VM, Nazer M, Bassett K, Wright JM.

Cochrane Database Syst Rev. 2014 May 29;(5):CD003824. doi: 10.1002/14651858.CD003824.pub2. Review.

PMID:
24869750
20.

[Guidelines on treatment of hypertension in the elderly, 1995--a tentative plan for comprehensive research projects on aging and health-- Members of the Research Group for "Guidelines on Treatment of Hypertension in the Elderly", Comprehensive Research Projects on Aging and Health, the Ministry of Health and Welfare of Japan].

Ogihara T, Hiwada K, Matsuoka H, Matsumoto M, Shimamoto K, Ouchi Y, Abe I, Fujishima M, Morimoto S, Nakahashi T, Mikami H, Kohara K, Takasaki M, Takizawa S, Kiyohara Y, Ibayashi S, Eto M, Ishimitsu T, Nakamura T, Masusa A, Takagawa Y.

Nihon Ronen Igakkai Zasshi. 1996 Dec;33(12):945-75. Japanese.

Items per page

Supplemental Content

Support Center